Israel
· Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 717.72 million. The enterprise value is 526.82 million.
| Market Cap | 717.72M |
| Enterprise Value | 526.82M |
Important Dates
The last earnings date was Tuesday, November 25, 2025.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 12.96% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 14.77.
| PE Ratio | 14.77 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | 8.38 |
| P/OCF Ratio | 6.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.43, with an EV/FCF ratio of 6.15.
| EV / Earnings | 12.07 |
| EV / Sales | 0.58 |
| EV / EBITDA | 5.43 |
| EV / EBIT | 10.83 |
| EV / FCF | 6.15 |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.86 |
| Quick Ratio | 1.98 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.57 |
| Interest Coverage | 17.05 |
Financial Efficiency
Return on equity (ROE) is 7.38% and return on invested capital (ROIC) is 5.02%.
| Return on Equity (ROE) | 7.38% |
| Return on Assets (ROA) | 3.60% |
| Return on Invested Capital (ROIC) | 5.02% |
| Return on Capital Employed (ROCE) | 7.80% |
| Revenue Per Employee | 5.14M |
| Profits Per Employee | 245,146 |
| Employee Count | 178 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 4.09 |
Taxes
In the past 12 months, Ilex Medical has paid 18.20 million in taxes.
| Income Tax | 18.20M |
| Effective Tax Rate | 27.27% |
Stock Price Statistics
The stock price has decreased by -21.05% in the last 52 weeks. The beta is 0.00, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -21.05% |
| 50-Day Moving Average | 6,573.84 |
| 200-Day Moving Average | 6,401.50 |
| Relative Strength Index (RSI) | 40.40 |
| Average Volume (20 Days) | 933 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 915.05 million and earned 43.64 million in profits. Earnings per share was 3.90.
| Revenue | 915.05M |
| Gross Profit | 210.53M |
| Operating Income | 57.02M |
| Pretax Income | 66.73M |
| Net Income | 43.64M |
| EBITDA | 91.73M |
| EBIT | 57.02M |
| Earnings Per Share (EPS) | 3.90 |
Balance Sheet
The company has 239.86 million in cash and 48.96 million in debt, giving a net cash position of 190.90 million or 17.06 per share.
| Cash & Cash Equivalents | 239.86M |
| Total Debt | 48.96M |
| Net Cash | 190.90M |
| Net Cash Per Share | 17.06 |
| Equity (Book Value) | 673.74M |
| Book Value Per Share | 60.09 |
| Working Capital | 445.31M |
Cash Flow
In the last 12 months, operating cash flow was 110.28 million and capital expenditures -24.65 million, giving a free cash flow of 85.63 million.
| Operating Cash Flow | 110.28M |
| Capital Expenditures | -24.65M |
| Free Cash Flow | 85.63M |
| FCF Per Share | 7.65 |
Margins
Gross margin is 23.01%, with operating and profit margins of 6.23% and 4.77%.
| Gross Margin | 23.01% |
| Operating Margin | 6.23% |
| Pretax Margin | 7.29% |
| Profit Margin | 4.77% |
| EBITDA Margin | 10.02% |
| EBIT Margin | 6.23% |
| FCF Margin | 9.36% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -10.63% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.27% |
| Buyback Yield | 0.18% |
| Shareholder Yield | 2.08% |
| Earnings Yield | 6.08% |
| FCF Yield | 11.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |